AMLX - Financial Reports List - Amylyx Pharmaceuticals, Inc. - IntrinsicAlpha

Amylyx Pharmaceuticals, Inc. AMLX

Healthcare - Biotechnology - NASDAQ - US

$ 4.92

6.28 %

$ 436 M

Market Cap

-0.95

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-0.61%	-793.62%	-2102.07%
Annual Report	FY	10-K	2024-12-31	-77.06%	-612.42%	-811.12%
Quarterly Report	Q3	8-K	2024-09-30	-99.59%	-347.98%	-404.17%
Quarterly Report	Q2	8-K	2024-06-30	-1.04%	-329.35%	-264.52%
Quarterly Report	Q1	8-K	2024-03-31	24.10%	-7552.00%	-5848.86%
Quarterly Report	Q4	8-K	2023-12-31	395.54%	111.08%	104.34%
Annual Report	FY	10-K	2023-12-31	1612.94%	124.84%	119.27%
Quarterly Report	Q3	8-K	2023-09-30	29666.09%	138.87%	134.23%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	140.83%	137.23%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	103.29%	95.71%

1